The proposed bill, General Assembly Proposed Bill No. 6810, aims to enhance transparency among health care entities that benefit from prescription drug discounts under Section 340B of the Public Health Service Act. The bill mandates that these covered entities must file periodic reports detailing how they utilize the savings from these discounts to benefit patients. This reporting requirement is established as a condition for eligibility to receive Medicaid reimbursement.

The intent of the bill is to ensure that Medicaid funding is withheld from covered entities that fail to provide adequate information on the application of their drug discount savings. By implementing this requirement, the bill seeks to promote accountability and ensure that the financial benefits derived from drug discounts are effectively translated into patient care improvements.